422 jobs for “Professional Services”
Contributes to the design, execution, analysis and reporting of hepatology clinical studies across all development phases, working with clinical operations, biostatistics, data management and regulatory affairs. Reviews safety, efficacy, biomarker and PK/PD data, supports protocol and CSR development, and engages with investigators and sites. Based on-site in London or Waltham, MA.
Owns operational delivery of diagnostics across early and late-stage oncology trials, covering biosample collection, processing and storage, and implementation of clinical trial assays at reference and central labs and CROs. Works in a matrix with biomarker, clinical operations, data management, regulatory and procurement colleagues, managing vendors, contracts and data transfer agreements while keeping studies audit-ready.
Provides medical and scientific leadership in pharmacovigilance and risk management for oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and Safety Review Teams, and presents to senior governance committees and regulators. Hybrid role based in the UK, Belgium, Poland or Italy.
Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. The role is hybrid across the UK, Belgium, Poland or Italy, with on-site attendance for key meetings.
Strategically leads global development of an oncology medicine from clinical Proof of Concept to approval in first major markets, acting as single point of accountability. Builds and leads a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, driving evidence packages, governance decisions and lifecycle plans.
Leads the global medical strategy for the Allergy therapy area, chairing the cross-functional product medical team and directing evidence generation, medical brand planning and scientific communications across the asset lifecycle. Partners with R&D, Commercial and priority markets, and coaches a team of direct reports within a matrixed global organisation.
Leads clinical development medical activities for cardiovascular and vascular programs across early and later phase studies, shaping clinical development plans, study designs and translational strategies. Provides medical monitoring and safety oversight, leads the clinical matrix team, and engages with regulators, KOLs and cross-functional partners in a hybrid working model.
GSK · 10000+ people · Public
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.
mRNA · Checkpoint Inhibitors
GSK · 10000+ people · Public
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.
mRNA · Personalized Vaccine Manufacturing · Checkpoint Inhibitors
GSK · 10000+ people · Public
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.
mRNA · Checkpoint Inhibitors
GSK · 10000+ people · Public
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and serves as asset spokesperson to senior governance boards.
mRNA · Checkpoint Inhibitors
Leads clinical development medical activities for cardiovascular and vascular programs across early and later phase studies, shaping clinical development plans, study designs and translational strategies. Serves as clinical lead for a matrix team, providing medical monitoring, regulatory input and safety oversight while working with biology, regulatory, commercial and operations colleagues.
Leads clinical development medical activities for cardiovascular and vascular programs across early and late-phase studies, shaping clinical development plans, study designs and translational strategies. Serves as clinical lead for a matrix team, providing medical monitoring, regulatory input and safety oversight while working with biology, regulatory, commercial and operations colleagues.
Provides clinical and scientific leadership across cardiovascular clinical development programmes, shaping study designs, translational plans and regulatory documents within the Respiratory, Immunology & Inflammation Research Unit. Leads a Clinical Matrix Team, oversees participant safety and medical monitoring, and works cross-functionally with biology, regulatory, statistics and commercial partners. Hybrid working with at least two days per week on-site.
Leads clinical development strategy for cardiovascular assets within the Respiratory, Immunology & Inflammation Research Unit, designing clinical development plans, protocols and regulatory documents while providing medical monitoring and safety oversight. Chairs the Clinical Matrix Team and serves as primary clinical contact for regulators, investigators and key external experts across early and late-stage programs.
